FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

324480006: Product containing precisely rifampicin 300 milligram/1 each conventional release oral capsule (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
3682671012 Rifampicin 300 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3682673010 Product containing precisely rifampicin 300 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3682674016 Rifampin 300 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rifampicin 300 mg oral capsule Is a Product containing only rifampicin (medicinal product) true Inferred relationship Some
Rifampicin 300 mg oral capsule Has manufactured dose form Oral capsule true Inferred relationship Some
Rifampicin 300 mg oral capsule Has unit of presentation Capsule (unit of presentation) true Inferred relationship Some
Rifampicin 300 mg oral capsule Has basis of strength substance (attribute) Rifampicin true Inferred relationship Some 1
Rifampicin 300 mg oral capsule Has presentation strength numerator unit mg true Inferred relationship Some 1
Rifampicin 300 mg oral capsule Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Some 1
Rifampicin 300 mg oral capsule Has precise active ingredient Rifampicin true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

Back to Start